- published: 23 Oct 2015
- views: 108
Create your page here
Wednesday, 16 March 2016
-
remove the playlistAstellas Pharma
- remove the playlistAstellas Pharma
back to playlist
No Copyright Intended
Advertiser Astellas Pharma
Ad URL http://www.mybladder.com
- published: 14 Mar 2014
- views: 11741
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma US, Inc. at Mandalay Bay in Las Vegas.
- published: 18 Jun 2010
- views: 1111
The adage "A picture is worth a thousand words" refers to the notion that a complex idea can be conveyed with a still image. It
also characterizes one of the main goals of visualization, making it possible to absorb large amounts of data quickly. Establishing
a process, means putting together a process map first 1) from the beginning to the end result 2) those responsible to perform
what tasks 3) the regulatory, business, or technology requirements that affect the process 4) all the steps needed to ensure the process is done completely, and on time. Having an effective tool that enables sharing the processes and providing a "one stop shop" for obtaining multiple services aids in helping staff to process information quickly and easily. Casewise is our tool of choice that enables us to share this information with our staff to help them understand what the Astellas Development organization does.
- published: 30 Apr 2014
- views: 282
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in Northbrook Illinois where she is the Global Head responsible for Global Process Development / Improvement and Standards Management. Tammy was instrumental in bringing Casewise into Astellas. She is responsible for leading process mapping activities, managing (nondrug) process development and improvement, and setting standards for the Astellas Global Development organization. Tammy started her career in the pharmaceutical industry in 1983 holding positions of increasing responsibility at G.D. Searle, PAREXEL International, and presently at Astellas since 2005. Watch her 25 Yr event presentation here : http://youtu.be/PbKjSkJk5pk
- published: 14 May 2014
- views: 258
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2S vrij bij geneesmiddelenfabrikant Astellas Pharma.
Een medewerker van de technische dienst had 5 liter van de zwavelwaterstof, zo wordt het gas in de volksmond genoemd, laten vallen. De man raakte onwel en is, bij kennis, in de frisse lucht gebracht. Hij is voor controle naar het ziekenhuis gebracht. Het gaat nu goed met de man.
Hulpverleningsdiensten rukten massaal uit en een team van de gaspakken ontsmettingsdienst uit Emmen hebben het pand onderzocht. Het laboratorium en de productiehal werden ontruimd, waardoor honderd mensen het pand moesten verlaten.
Rond 15.30 uur gaf de brandweer het pand vrij en kort daarna mochten de medewerkers van geneesmiddelenfabrikant Astellas Pharma het pand weer in.
- published: 19 Sep 2012
- views: 1191
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty at Huntingdon Life Sciences.
- published: 01 Dec 2007
- views: 1887
Intervista al Dott. Chris Thomson, Direttore Business Unit Oncology, Astellas Europe
- published: 23 Feb 2014
- views: 161
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all of the company's equity interests in Perseid Therapeutics at the current exercise price of $76.0 million.
Under the terms of the joint-venture arrangement, the company transferred substantially all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid and granted Astellas an option to acquire all of its ownership interest in Perseid at specified exercise prices.
- published: 17 Mar 2011
- views: 196
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha?, TYO: 4503) is a Japanese pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha?) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社, Fujisawa Yakuhin Kōgyō Kabushiki-gaisha?).
Astellas' franchise areas are urology, immunology (transplantation), dermatology, cardiology, and infectious disease. Priority areas for R&D are infectious diseases, diabetes, gastrointestinal diseases, oncology, and diseases of the central nervous system.
The company's headquarters are in Tokyo, with research centers in Tsukuba and Osaka. Clinical development is centred in Deerfield, Illinois and Leiderdorp, Netherlands. Combined revenues of the two pre-merger companies were $7.9 billion in 2004. Worldwide the company employs about 17,000 people.
Fujisawa Shoten was started in 1894 by Tomokichi Fujisawa in Osaka, and was renamed Fujisawa Pharmaceutical Co. in 1943.
This page contains text from Wikipedia, the Free Encyclopedia -
http://en.wikipedia.org/wiki/Astellas_Pharma
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
7:02Imagevideo Astellas Pharma
Imagevideo Astellas PharmaImagevideo Astellas Pharma
Astellas Pharma Imagevideo -
2:24Astellas Pharmaceutical Mycamine® Whistleblower Settlement
Astellas Pharmaceutical Mycamine® Whistleblower Settlement -
1:01TV Commercial - Astellas Pharma - Myrbetriq
TV Commercial - Astellas Pharma - MyrbetriqTV Commercial - Astellas Pharma - Myrbetriq
No Copyright Intended Advertiser Astellas Pharma Ad URL http://www.mybladder.com -
4:16Astellas Pharma US, Inc. Careers.avi
Astellas Pharma US, Inc. Careers.aviAstellas Pharma US, Inc. Careers.avi
Astellas corporate video -
6:36Maura Bivens addresses Astellas Pharma sales meeting
Maura Bivens addresses Astellas Pharma sales meetingMaura Bivens addresses Astellas Pharma sales meeting
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma US, Inc. at Mandalay Bay in Las Vegas. -
0:31Astellas Pharma Inc
Astellas Pharma IncAstellas Pharma Inc
-
18:50Tammy Sulaiman, Astellas Pharma Global Development
Tammy Sulaiman, Astellas Pharma Global DevelopmentTammy Sulaiman, Astellas Pharma Global Development
The adage "A picture is worth a thousand words" refers to the notion that a complex idea can be conveyed with a still image. It also characterizes one of the main goals of visualization, making it possible to absorb large amounts of data quickly. Establishing a process, means putting together a process map first 1) from the beginning to the end result 2) those responsible to perform what tasks 3) the regulatory, business, or technology requirements that affect the process 4) all the steps needed to ensure the process is done completely, and on time. Having an effective tool that enables sharing the processes and providing a "one stop shop" for obtaining multiple services aids in helping staff to process information quickly and easily. Casewise is our tool of choice that enables us to share this information with our staff to help them understand what the Astellas Development organization does. -
1:21Astellas Pharma, Tammy Sulaiman
Astellas Pharma, Tammy SulaimanAstellas Pharma, Tammy Sulaiman
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in Northbrook Illinois where she is the Global Head responsible for Global Process Development / Improvement and Standards Management. Tammy was instrumental in bringing Casewise into Astellas. She is responsible for leading process mapping activities, managing (nondrug) process development and improvement, and setting standards for the Astellas Global Development organization. Tammy started her career in the pharmaceutical industry in 1983 holding positions of increasing responsibility at G.D. Searle, PAREXEL International, and presently at Astellas since 2005. Watch her 25 Yr event presentation here : http://youtu.be/PbKjSkJk5pk -
1:17Gevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
Gevaarlijke gas vrijgekomen bij Astellas Pharma in MeppelGevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2S vrij bij geneesmiddelenfabrikant Astellas Pharma. Een medewerker van de technische dienst had 5 liter van de zwavelwaterstof, zo wordt het gas in de volksmond genoemd, laten vallen. De man raakte onwel en is, bij kennis, in de frisse lucht gebracht. Hij is voor controle naar het ziekenhuis gebracht. Het gaat nu goed met de man. Hulpverleningsdiensten rukten massaal uit en een team van de gaspakken ontsmettingsdienst uit Emmen hebben het pand onderzocht. Het laboratorium en de productiehal werden ontruimd, waardoor honderd mensen het pand moesten verlaten. Rond 15.30 uur gaf de brandweer het pand vrij en kort daarna mochten de medewerkers van geneesmiddelenfabrikant Astellas Pharma het pand weer in. -
2:16Astellas Pharma protested for HLS ties
Astellas Pharma protested for HLS tiesAstellas Pharma protested for HLS ties
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty at Huntingdon Life Sciences. -
2:31La ricerca oncologica di Astellas Pharma
La ricerca oncologica di Astellas PharmaLa ricerca oncologica di Astellas Pharma
Intervista al Dott. Chris Thomson, Direttore Business Unit Oncology, Astellas Europe -
0:39Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In PerseidMaxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all of the company's equity interests in Perseid Therapeutics at the current exercise price of $76.0 million. Under the terms of the joint-venture arrangement, the company transferred substantially all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid and granted Astellas an option to acquire all of its ownership interest in Perseid at specified exercise prices. -
1:06News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder ResponseNews Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
3/31/2010-The Wall Street Journal reported Wednesday that Astellas Pharma will extend a tender offer for OSI Pharmaceuticals (NASDAQ:OSIP) shares that values the U.S. cancer drug developer at $3.5 billion by three weeks to April 23. The tender offer was originally to be finished March 31 in the U.S. By Tuesday, 37,858 OSI shares had been tendered for sale to Astellas, accounting for just 0.06% of OSI's outstanding shares, a spokesman for the Tokyo-based drug maker said. The tender offer result backs analysts' views that Astellas' offering price of $52 a share isn't attractive to OSI shareholders, according to the Journal. OSI's shares finished at $60.06 on Tuesday. -
11:32De Vaulx Likes Secom, Astellas Pharma, Oil and Gas
De Vaulx Likes Secom, Astellas Pharma, Oil and GasDe Vaulx Likes Secom, Astellas Pharma, Oil and Gas
Sept. 26 (Bloomberg) -- Charles De Vaulx, portfolio manager at International Value Advisers LLC, talks about the impact of the European sovereign-debt crisis on U.S. investors, his value-investment strategy and some of his stock picks including Secom Co. and Astellas Pharma Inc. De Vaulx speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
- 2007
- Adenosine
- Advantest
- Ajinomoto
- Alefacept
- All Nippon Airways
- Alps Electric Co.
- Amphotericin B
- Anti-fungal
- Antibiotic
- Asahi Breweries
- Asahi Glass Co.
- Asahi Kasei
- Astellas Pharma
- Bank of Yokohama
- Bridgestone
- Canon (company)
- Cardiology
- Casio
- Chiba Bank
- Chiyoda Corporation
- Chubu Electric Power
- Citizen Watch Co.
- Clarion Co., Ltd.
- Comsys
- Conivaptan
- Credit Saison
- Dai Nippon Printing
- Daiichi Sankyo
- Daikin Industries
- Daiwa House
- Deerfield, Illinois
- Denki Kagaku Kogyo
- Denso
- Dentsu
- Dermatology
- Diabetes
- Dowa Holdings
- Ebara Corporation
- Eczema
- Eisai Co.
- Erlotinib
- FANUC
- Fast Retailing
- Fiscal year
- Fuji Electric
- Fujifilm
- Fujikura
- Fujitsu
- Furukawa Electric
- Furukawa Group
- GS Yuasa
- Heiwa Real Estate
- Hino Motors
- Hitachi
- Hitachi Zosen
- Hokuetsu Paper Mills
- Honda
- Hoya Corporation
- Hydrochloride
- Hyponatremia
- IHI Corporation
- Immunology
- Infectious disease
- Inpex
- Isetan
- Isuzu
- Itochu
- J. Front Retailing
- Japan
- Japan Steel Works
- Japan Tobacco
- Japanese yen
- JFE Holdings
- JGC Corporation
- JTEKT
- JX Holdings
- K Line
- Kabushiki kaisha
- Kajima
- Kao Corporation
- KDDI
- Keio Corporation
- Keyence
- Kikkoman
- Kobe Steel
- Komatsu Limited
- Konami
- Konica Minolta
- Kubota
- Kuraray
- Kyocera
- Kyowa Hakko Kirin
- Leiderdorp
- Lung cancer
- Marubeni
- Maruha Nichiro
- Marui
- Matsui Securities
- Mazda
- Meidensha
- Meiji Holdings
- Methadone
- Micafungin
- Migraine
- Minebea
- Mitsubishi Electric
- Mitsubishi Logistics
- Mitsubishi Materials
- Mitsubishi Motors
- Mitsubishi Rayon
- Mitsui & Co.
- Mitsui Chemicals
- Mitsui Fudosan
- Mitsui O.S.K. Lines
- Mitsukoshi
- Mitsumi
- Mizuho Securities
- Murata Manufacturing
- Narcotics
- NEC
- Net income
- Netherlands
- NGK Insulators
- Nichirei
- Nidec Corporation
- Nikkei 225
- Nikon
- Nintendo
- Nippon Express
- Nippon Ham
- Nippon Kayaku
- Nippon Light Metal
- Nippon Oil
- Nippon Paper Group
- Nippon Sheet Glass
- Nippon Soda
- Nippon Steel
- Nippon Suisan Kaisha
- Nippon Yusen
- Nissan Motors
- Nisshin Seifun Group
- Nisshin Steel
- Nisshinbo Industries
- Nitto Boseki
- Nitto Denko
- NKSJ
- Nomura Holdings
- NSK Ltd.
- NTN Corporation
- NTT Data
- NTT docomo
- Obayashi Corporation
- Oji Paper Company
- Okuma Corporation
- Olympus Corporation
- Oncology
- Organ rejection
- Organ transplant
- ORIX
- Osaka
- Osaka Gas
- OSI Pharmaceuticals
- Overactive bladder
- Pacific Metals
- Pancreatic cancer
- Pioneer Corporation
- Portal Companies
- Psoriasis
- Public company
- Regadenoson
- Research
- Resona Holdings
- Ricoh
- Rohm
- Royal Dutch Shell
- Sanyo
- Sapporo Brewery
- Secom
- Sekisui House
- Sharp Corporation
- Shimizu Corporation
- Shin-Etsu Chemical
- Shinsei Bank
- Shionogi
- Shiseido
- Shizuoka Bank
- Showa Denko
- SoftBank
- Sojitz
- Sompo Japan
- Sony
- Sumatriptan
- Sumco
- Sumitomo Chemical
- Sumitomo Corporation
- Suzuki
- T&D; Holdings
- Tacrolimus
- Taiheiyo Cement
- Taisei Corporation
- Taiwan
- Taiyo Yuden
- Takara Holdings
- Takashimaya
- Tamsulosin
- TDK
- Teijin
- Telavancin
- Template Nikkei 225
- Template TOPIX 100
- Terumo
- Ticker symbol
- Tobu Railway
- Toho
- Toho Zinc
- Tokai Carbon
- Tokio Marine
- Tokyo
- Tokyo Dome
- Tokyo Electron
- Tokyo Gas
- Tokyo Stock Exchange
- Tokyu Corporation
- Tokyu Land
- Topix
- Toppan Printing
- Toray Industries
- Toshiba
- Tosoh
- Toto Ltd.
- Toyo Seikan Kaisha
- Toyobo
- Toyota
- Toyota Tsusho
- Trend Micro
- Tsukuba
- Ube Industries
- Unitika
- Uny
- Urology
- Yahoo! Japan
- Yamada Denki
- Yamaha Corporation
- Yamato Transport
- Yokogawa Electric
- ÆON
- Æon (company)
-
Imagevideo Astellas Pharma
Astellas Pharma Imagevideo -
-
TV Commercial - Astellas Pharma - Myrbetriq
No Copyright Intended Advertiser Astellas Pharma Ad URL http://www.mybladder.com -
Astellas Pharma US, Inc. Careers.avi
Astellas corporate video -
Maura Bivens addresses Astellas Pharma sales meeting
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma US, Inc. at Mandalay Bay in Las Vegas. -
Astellas Pharma Inc
-
Tammy Sulaiman, Astellas Pharma Global Development
The adage "A picture is worth a thousand words" refers to the notion that a complex idea can be conveyed with a still image. It also characterizes one of the main goals of visualization, making it possible to absorb large amounts of data quickly. Establishing a process, means putting together a process map first 1) from the beginning to the end result 2) those responsible to perform what tasks 3) the regulatory, business, or technology requirements that affect the process 4) all the steps needed to ensure the process is done completely, and on time. Having an effective tool that enables sharing the processes and providing a "one stop shop" for obtaining multiple services aids in helping staff to process information quickly and easily. Casewise is our tool of choice that enables us to sh... -
Astellas Pharma, Tammy Sulaiman
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in Northbrook Illinois where she is the Global Head responsible for Global Process Development / Improvement and Standards Management. Tammy was instrumental in bringing Casewise into Astellas. She is responsible for leading process mapping activities, managing (nondrug) process development and improvement, and setting standards for the Astellas Global Development organization. Tammy started her career in the pharmaceutical industry in 1983 holding positions of increasing responsibility at G.D. Searle, PAREXEL International, and presently at Astellas since 2005. Watch her 25 Yr event presentation here : http://youtu.be/PbKjSkJk5pk -
Gevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2S vrij bij geneesmiddelenfabrikant Astellas Pharma. Een medewerker van de technische dienst had 5 liter van de zwavelwaterstof, zo wordt het gas in de volksmond genoemd, laten vallen. De man raakte onwel en is, bij kennis, in de frisse lucht gebracht. Hij is voor controle naar het ziekenhuis gebracht. Het gaat nu goed met de man. Hulpverleningsdiensten rukten massaal uit en een team van de gaspakken ontsmettingsdienst uit Emmen hebben het pand onderzocht. Het laboratorium en de productiehal werden ontruimd, waardoor honderd mensen het pand moesten verlaten. Rond 15.30 uur gaf de brandweer het pand vrij en kort daarna mochten de medewerkers van geneesmiddelenfabrikant Astellas Pharma het pand wee... -
Astellas Pharma protested for HLS ties
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty at Huntingdon Life Sciences. -
La ricerca oncologica di Astellas Pharma
Intervista al Dott. Chris Thomson, Direttore Business Unit Oncology, Astellas Europe -
Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all of the company's equity interests in Perseid Therapeutics at the current exercise price of $76.0 million. Under the terms of the joint-venture arrangement, the company transferred substantially all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid and granted Astellas an option to acquire all of its ownership interest in Perseid at specified exercise prices. -
News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
3/31/2010-The Wall Street Journal reported Wednesday that Astellas Pharma will extend a tender offer for OSI Pharmaceuticals (NASDAQ:OSIP) shares that values the U.S. cancer drug developer at $3.5 billion by three weeks to April 23. The tender offer was originally to be finished March 31 in the U.S. By Tuesday, 37,858 OSI shares had been tendered for sale to Astellas, accounting for just 0.06% of OSI's outstanding shares, a spokesman for the Tokyo-based drug maker said. The tender offer result backs analysts' views that Astellas' offering price of $52 a share isn't attractive to OSI shareholders, according to the Journal. OSI's shares finished at $60.06 on Tuesday. -
De Vaulx Likes Secom, Astellas Pharma, Oil and Gas
Sept. 26 (Bloomberg) -- Charles De Vaulx, portfolio manager at International Value Advisers LLC, talks about the impact of the European sovereign-debt crisis on U.S. investors, his value-investment strategy and some of his stock picks including Secom Co. and Astellas Pharma Inc. De Vaulx speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg) -
2009 workforceChicago Astellas Pharma US Panel
2009 workforceChicago Astellas Pharma US Panel -
Zinc Testimonials - Astellas Pharma
"Zinc really is a company that listens to its customers" - Astellas Pharma To learn more about Zinc, visit our website http://www.zinc-ahead.com -
Cytori in Equity Deal with Astellas Pharma
"Cytori Therapeutics (CYTX) and Astellas Pharma Inc. have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regenerative cells for the treatment of serious illnesses for which there is no fundamental treatment. Astellas will purchase approximately 1.43 million unregistered shares of Cytori common stock at $7.00 per share for net proceeds to Cytori of $10 million. As part of the agreement, Cytori granted Astellas the following additional rights: Two year right of first refusal for a worldwide research, development and/or commercialization partnership using Cytori's products and technologies in the treatment of liver disease; non-voting observer seat on Cytori's board-of-directors; and participation in a newly formed scientific advisory board... -
Astellas Pharma Europ B.V. (Promotion Film for LED Monitors)
Promo reel -
Corporate Event Video Animation | Astellas Pharma 'Lead The Fight' | Motion Videos UK
Working in collaboration with Rapport Events we produced a corporate event video production for Astellas Pharmaceuticals and it fit right in with the urban-style branding that they adopted for their corporate event in Stockholm. The video was designed to raise awareness of the event from their stakeholders. Find out more: http://goo.gl/Ppld9T -
Impegno in Oncologia di Astellas Pharma
Intervista al Dr. Ermanno Buratti, Direttore Generale di Astellas Pharma -
Astellas Pharma Canada, 'We're Changing Tomorrow'.
Astellas Pharma employees globally join together to help give back to their community and show their support at Camp Trilium, a cancer camp that helps children with cancer and their families. -
Preview: Astellas Pharma Business & Opportunity Webinar
Watch this webinar for an outline of Japan's 2nd largest research based pharmaceutical company and details of business opportunities your company could take with Astellas Pharma Inc. Visit http://www.exporttojapan.co.uk/sector/life-sciences for more info. -
Astellas Pharma: A Testing Automation Success Story
Learn how Astellas utilized best practices to revamp their testing automation, in this RAINMAKER 2013 session presented by Bruce Wood and Stacey Varghese from Astellas Pharma, and JB Pringuey from Model N. Model N is the pioneer and leading provider of Revenue Management cloud solutions for the Life Sciences and High Technology industries. Learn more at https://www.modeln.com Twitter | https://www.twitter.com/modeln Facebook | https://www.facebook.com/ModelNInc LinkedIn | https://www.linkedin.com/company/model-n Google + | https://plus.google.com/+Modeln-inc
Imagevideo Astellas Pharma
- Order: Reorder
- Duration: 7:02
- Updated: 23 Oct 2015
- views: 108
Astellas Pharma Imagevideo
Astellas Pharma Imagevideo
wn.com/Imagevideo Astellas Pharma
Astellas Pharmaceutical Mycamine® Whistleblower Settlement
- Order: Reorder
- Duration: 2:24
- Updated: 17 Apr 2014
- views: 589
Check out the Full DOJ press release here: http://www.justice.gov/opa/pr/2014/April/14-civ-391.html
Visit my website for even more information: http://cqhfirm....
Check out the Full DOJ press release here: http://www.justice.gov/opa/pr/2014/April/14-civ-391.html
Visit my website for even more information: http://cqhfirm.com/
wn.com/Astellas Pharmaceutical Mycamine® Whistleblower Settlement
TV Commercial - Astellas Pharma - Myrbetriq
- Order: Reorder
- Duration: 1:01
- Updated: 14 Mar 2014
- views: 11741
No Copyright Intended
Advertiser Astellas Pharma
Ad URL http://www.mybladder.com
- published: 14 Mar 2014
- views: 11741
Astellas Pharma US, Inc. Careers.avi
- Order: Reorder
- Duration: 4:16
- Updated: 09 Dec 2008
- views: 1163
Astellas corporate video
Astellas corporate video
wn.com/Astellas Pharma Us, Inc. Careers.Avi
Maura Bivens addresses Astellas Pharma sales meeting
- Order: Reorder
- Duration: 6:36
- Updated: 18 Jun 2010
- views: 1111
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma US, Inc. at Mandalay Bay in Las Vegas.
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma US, Inc. at Mandalay Bay in Las Vegas.
wn.com/Maura Bivens Addresses Astellas Pharma Sales Meeting
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma US, Inc. at Mandalay Bay in Las Vegas.
- published: 18 Jun 2010
- views: 1111
Astellas Pharma Inc
- Order: Reorder
- Duration: 0:31
- Updated: 25 Oct 2011
- views: 1682
- published: 25 Oct 2011
- views: 1682
Tammy Sulaiman, Astellas Pharma Global Development
- Order: Reorder
- Duration: 18:50
- Updated: 30 Apr 2014
- views: 282
The adage "A picture is worth a thousand words" refers to the notion that a complex idea can be conveyed with a still image. It
also characterizes one of the m...
The adage "A picture is worth a thousand words" refers to the notion that a complex idea can be conveyed with a still image. It
also characterizes one of the main goals of visualization, making it possible to absorb large amounts of data quickly. Establishing
a process, means putting together a process map first 1) from the beginning to the end result 2) those responsible to perform
what tasks 3) the regulatory, business, or technology requirements that affect the process 4) all the steps needed to ensure the process is done completely, and on time. Having an effective tool that enables sharing the processes and providing a "one stop shop" for obtaining multiple services aids in helping staff to process information quickly and easily. Casewise is our tool of choice that enables us to share this information with our staff to help them understand what the Astellas Development organization does.
wn.com/Tammy Sulaiman, Astellas Pharma Global Development
The adage "A picture is worth a thousand words" refers to the notion that a complex idea can be conveyed with a still image. It
also characterizes one of the main goals of visualization, making it possible to absorb large amounts of data quickly. Establishing
a process, means putting together a process map first 1) from the beginning to the end result 2) those responsible to perform
what tasks 3) the regulatory, business, or technology requirements that affect the process 4) all the steps needed to ensure the process is done completely, and on time. Having an effective tool that enables sharing the processes and providing a "one stop shop" for obtaining multiple services aids in helping staff to process information quickly and easily. Casewise is our tool of choice that enables us to share this information with our staff to help them understand what the Astellas Development organization does.
- published: 30 Apr 2014
- views: 282
Astellas Pharma, Tammy Sulaiman
- Order: Reorder
- Duration: 1:21
- Updated: 14 May 2014
- views: 258
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in Northbrook Illinois where she is the Global Head responsible for Glob...
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in Northbrook Illinois where she is the Global Head responsible for Global Process Development / Improvement and Standards Management. Tammy was instrumental in bringing Casewise into Astellas. She is responsible for leading process mapping activities, managing (nondrug) process development and improvement, and setting standards for the Astellas Global Development organization. Tammy started her career in the pharmaceutical industry in 1983 holding positions of increasing responsibility at G.D. Searle, PAREXEL International, and presently at Astellas since 2005. Watch her 25 Yr event presentation here : http://youtu.be/PbKjSkJk5pk
wn.com/Astellas Pharma, Tammy Sulaiman
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in Northbrook Illinois where she is the Global Head responsible for Global Process Development / Improvement and Standards Management. Tammy was instrumental in bringing Casewise into Astellas. She is responsible for leading process mapping activities, managing (nondrug) process development and improvement, and setting standards for the Astellas Global Development organization. Tammy started her career in the pharmaceutical industry in 1983 holding positions of increasing responsibility at G.D. Searle, PAREXEL International, and presently at Astellas since 2005. Watch her 25 Yr event presentation here : http://youtu.be/PbKjSkJk5pk
- published: 14 May 2014
- views: 258
Gevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
- Order: Reorder
- Duration: 1:17
- Updated: 19 Sep 2012
- views: 1191
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2S vrij bij geneesmiddelenfabrikant Astellas Pharma.
Een medewerker v...
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2S vrij bij geneesmiddelenfabrikant Astellas Pharma.
Een medewerker van de technische dienst had 5 liter van de zwavelwaterstof, zo wordt het gas in de volksmond genoemd, laten vallen. De man raakte onwel en is, bij kennis, in de frisse lucht gebracht. Hij is voor controle naar het ziekenhuis gebracht. Het gaat nu goed met de man.
Hulpverleningsdiensten rukten massaal uit en een team van de gaspakken ontsmettingsdienst uit Emmen hebben het pand onderzocht. Het laboratorium en de productiehal werden ontruimd, waardoor honderd mensen het pand moesten verlaten.
Rond 15.30 uur gaf de brandweer het pand vrij en kort daarna mochten de medewerkers van geneesmiddelenfabrikant Astellas Pharma het pand weer in.
wn.com/Gevaarlijke Gas Vrijgekomen Bij Astellas Pharma In Meppel
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2S vrij bij geneesmiddelenfabrikant Astellas Pharma.
Een medewerker van de technische dienst had 5 liter van de zwavelwaterstof, zo wordt het gas in de volksmond genoemd, laten vallen. De man raakte onwel en is, bij kennis, in de frisse lucht gebracht. Hij is voor controle naar het ziekenhuis gebracht. Het gaat nu goed met de man.
Hulpverleningsdiensten rukten massaal uit en een team van de gaspakken ontsmettingsdienst uit Emmen hebben het pand onderzocht. Het laboratorium en de productiehal werden ontruimd, waardoor honderd mensen het pand moesten verlaten.
Rond 15.30 uur gaf de brandweer het pand vrij en kort daarna mochten de medewerkers van geneesmiddelenfabrikant Astellas Pharma het pand weer in.
- published: 19 Sep 2012
- views: 1191
Astellas Pharma protested for HLS ties
- Order: Reorder
- Duration: 2:16
- Updated: 01 Dec 2007
- views: 1887
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty at Huntingdon Life Sciences.
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty at Huntingdon Life Sciences.
wn.com/Astellas Pharma Protested For Hls Ties
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty at Huntingdon Life Sciences.
- published: 01 Dec 2007
- views: 1887
La ricerca oncologica di Astellas Pharma
- Order: Reorder
- Duration: 2:31
- Updated: 23 Feb 2014
- views: 161
Intervista al Dott. Chris Thomson, Direttore Business Unit Oncology, Astellas Europe
- published: 23 Feb 2014
- views: 161
Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
- Order: Reorder
- Duration: 0:39
- Updated: 17 Mar 2011
- views: 196
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all of the company's equity interests in Perseid Therapeutics at the curre...
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all of the company's equity interests in Perseid Therapeutics at the current exercise price of $76.0 million.
Under the terms of the joint-venture arrangement, the company transferred substantially all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid and granted Astellas an option to acquire all of its ownership interest in Perseid at specified exercise prices.
wn.com/Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all of the company's equity interests in Perseid Therapeutics at the current exercise price of $76.0 million.
Under the terms of the joint-venture arrangement, the company transferred substantially all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid and granted Astellas an option to acquire all of its ownership interest in Perseid at specified exercise prices.
- published: 17 Mar 2011
- views: 196
News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
- Order: Reorder
- Duration: 1:06
- Updated: 31 Mar 2010
- views: 530
3/31/2010-The Wall Street Journal reported Wednesday that Astellas Pharma will extend a tender offer for OSI Pharmaceuticals (NASDAQ:OSIP) shares that values th...
3/31/2010-The Wall Street Journal reported Wednesday that Astellas Pharma will extend a tender offer for OSI Pharmaceuticals (NASDAQ:OSIP) shares that values the U.S. cancer drug developer at $3.5 billion by three weeks to April 23.
The tender offer was originally to be finished March 31 in the U.S.
By Tuesday, 37,858 OSI shares had been tendered for sale to Astellas, accounting for just 0.06% of OSI's outstanding shares, a spokesman for the Tokyo-based drug maker said.
The tender offer result backs analysts' views that Astellas' offering price of $52 a share isn't attractive to OSI shareholders, according to the Journal.
OSI's shares finished at $60.06 on Tuesday.
wn.com/News Update Astellas Pharma Extends Tender Offer For Osi Pharma Amid Weak Shareholder Response
3/31/2010-The Wall Street Journal reported Wednesday that Astellas Pharma will extend a tender offer for OSI Pharmaceuticals (NASDAQ:OSIP) shares that values the U.S. cancer drug developer at $3.5 billion by three weeks to April 23.
The tender offer was originally to be finished March 31 in the U.S.
By Tuesday, 37,858 OSI shares had been tendered for sale to Astellas, accounting for just 0.06% of OSI's outstanding shares, a spokesman for the Tokyo-based drug maker said.
The tender offer result backs analysts' views that Astellas' offering price of $52 a share isn't attractive to OSI shareholders, according to the Journal.
OSI's shares finished at $60.06 on Tuesday.
- published: 31 Mar 2010
- views: 530
De Vaulx Likes Secom, Astellas Pharma, Oil and Gas
- Order: Reorder
- Duration: 11:32
- Updated: 26 Sep 2011
- views: 226
Sept. 26 (Bloomberg) -- Charles De Vaulx, portfolio manager at International Value Advisers LLC, talks about the impact of the European sovereign-debt crisis on...
Sept. 26 (Bloomberg) -- Charles De Vaulx, portfolio manager at International Value Advisers LLC, talks about the impact of the European sovereign-debt crisis on U.S. investors, his value-investment strategy and some of his stock picks including Secom Co. and Astellas Pharma Inc.
De Vaulx speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
wn.com/De Vaulx Likes Secom, Astellas Pharma, Oil And Gas
Sept. 26 (Bloomberg) -- Charles De Vaulx, portfolio manager at International Value Advisers LLC, talks about the impact of the European sovereign-debt crisis on U.S. investors, his value-investment strategy and some of his stock picks including Secom Co. and Astellas Pharma Inc.
De Vaulx speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
- published: 26 Sep 2011
- views: 226
2009 workforceChicago Astellas Pharma US Panel
- Order: Reorder
- Duration: 9:28
- Updated: 17 Aug 2009
- views: 442
2009 workforceChicago Astellas Pharma US Panel
2009 workforceChicago Astellas Pharma US Panel
wn.com/2009 Workforcechicago Astellas Pharma US Panel
Zinc Testimonials - Astellas Pharma
- Order: Reorder
- Duration: 2:23
- Updated: 19 May 2014
- views: 545
"Zinc really is a company that listens to its customers" - Astellas Pharma
To learn more about Zinc, visit our website http://www.zinc-ahead.com
"Zinc really is a company that listens to its customers" - Astellas Pharma
To learn more about Zinc, visit our website http://www.zinc-ahead.com
wn.com/Zinc Testimonials Astellas Pharma
"Zinc really is a company that listens to its customers" - Astellas Pharma
To learn more about Zinc, visit our website http://www.zinc-ahead.com
- published: 19 May 2014
- views: 545
Cytori in Equity Deal with Astellas Pharma
- Order: Reorder
- Duration: 1:00
- Updated: 07 Dec 2010
- views: 130
"Cytori Therapeutics (CYTX) and Astellas Pharma Inc. have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regene...
"Cytori Therapeutics (CYTX) and Astellas Pharma Inc. have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regenerative cells for the treatment of serious illnesses for which there is no fundamental treatment.
Astellas will purchase approximately 1.43 million unregistered shares of Cytori common stock at $7.00 per share for net proceeds to Cytori of $10 million.
As part of the agreement, Cytori granted Astellas the following additional rights: Two year right of first refusal for a worldwide research, development and/or commercialization partnership using Cytori's products and technologies in the treatment of liver disease; non-voting observer seat on Cytori's board-of-directors; and participation in a newly formed scientific advisory board."
wn.com/Cytori In Equity Deal With Astellas Pharma
"Cytori Therapeutics (CYTX) and Astellas Pharma Inc. have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regenerative cells for the treatment of serious illnesses for which there is no fundamental treatment.
Astellas will purchase approximately 1.43 million unregistered shares of Cytori common stock at $7.00 per share for net proceeds to Cytori of $10 million.
As part of the agreement, Cytori granted Astellas the following additional rights: Two year right of first refusal for a worldwide research, development and/or commercialization partnership using Cytori's products and technologies in the treatment of liver disease; non-voting observer seat on Cytori's board-of-directors; and participation in a newly formed scientific advisory board."
- published: 07 Dec 2010
- views: 130
Astellas Pharma Europ B.V. (Promotion Film for LED Monitors)
- Order: Reorder
- Duration: 5:01
- Updated: 01 May 2012
- views: 364
Promo reel
Promo reel
wn.com/Astellas Pharma Europ B.V. (Promotion Film For Led Monitors)
Corporate Event Video Animation | Astellas Pharma 'Lead The Fight' | Motion Videos UK
- Order: Reorder
- Duration: 2:19
- Updated: 28 Sep 2015
- views: 40
Working in collaboration with Rapport Events we produced a corporate event video production for Astellas Pharmaceuticals and it fit right in with the urban-styl...
Working in collaboration with Rapport Events we produced a corporate event video production for Astellas Pharmaceuticals and it fit right in with the urban-style branding that they adopted for their corporate event in Stockholm. The video was designed to raise awareness of the event from their stakeholders.
Find out more: http://goo.gl/Ppld9T
wn.com/Corporate Event Video Animation | Astellas Pharma 'Lead The Fight' | Motion Videos UK
Working in collaboration with Rapport Events we produced a corporate event video production for Astellas Pharmaceuticals and it fit right in with the urban-style branding that they adopted for their corporate event in Stockholm. The video was designed to raise awareness of the event from their stakeholders.
Find out more: http://goo.gl/Ppld9T
- published: 28 Sep 2015
- views: 40
Impegno in Oncologia di Astellas Pharma
- Order: Reorder
- Duration: 3:29
- Updated: 23 Feb 2014
- views: 223
Intervista al Dr. Ermanno Buratti, Direttore Generale di Astellas Pharma
- published: 23 Feb 2014
- views: 223
Astellas Pharma Canada, 'We're Changing Tomorrow'.
- Order: Reorder
- Duration: 3:35
- Updated: 05 Jun 2015
- views: 60
Astellas Pharma employees globally join together to help give back to their community and show their support at Camp Trilium, a cancer camp that helps children ...
Astellas Pharma employees globally join together to help give back to their community and show their support at Camp Trilium, a cancer camp that helps children with cancer and their families.
wn.com/Astellas Pharma Canada, 'We're Changing Tomorrow'.
Astellas Pharma employees globally join together to help give back to their community and show their support at Camp Trilium, a cancer camp that helps children with cancer and their families.
- published: 05 Jun 2015
- views: 60
Preview: Astellas Pharma Business & Opportunity Webinar
- Order: Reorder
- Duration: 1:24
- Updated: 02 May 2014
- views: 118
Watch this webinar for an outline of Japan's 2nd largest research based pharmaceutical company and details of business opportunities your company could take wit...
Watch this webinar for an outline of Japan's 2nd largest research based pharmaceutical company and details of business opportunities your company could take with Astellas Pharma Inc. Visit http://www.exporttojapan.co.uk/sector/life-sciences for more info.
wn.com/Preview Astellas Pharma Business Opportunity Webinar
Astellas Pharma: A Testing Automation Success Story
- Order: Reorder
- Duration: 31:21
- Updated: 22 Oct 2013
- views: 180
Learn how Astellas utilized best practices to revamp their testing automation, in this RAINMAKER 2013 session presented by Bruce Wood and Stacey Varghese from A...
Learn how Astellas utilized best practices to revamp their testing automation, in this RAINMAKER 2013 session presented by Bruce Wood and Stacey Varghese from Astellas Pharma, and JB Pringuey from Model N.
Model N is the pioneer and leading provider of Revenue Management cloud solutions for the Life Sciences and High Technology industries. Learn more at https://www.modeln.com
Twitter | https://www.twitter.com/modeln
Facebook | https://www.facebook.com/ModelNInc
LinkedIn | https://www.linkedin.com/company/model-n
Google + | https://plus.google.com/+Modeln-inc
wn.com/Astellas Pharma A Testing Automation Success Story
Learn how Astellas utilized best practices to revamp their testing automation, in this RAINMAKER 2013 session presented by Bruce Wood and Stacey Varghese from Astellas Pharma, and JB Pringuey from Model N.
Model N is the pioneer and leading provider of Revenue Management cloud solutions for the Life Sciences and High Technology industries. Learn more at https://www.modeln.com
Twitter | https://www.twitter.com/modeln
Facebook | https://www.facebook.com/ModelNInc
LinkedIn | https://www.linkedin.com/company/model-n
Google + | https://plus.google.com/+Modeln-inc
- published: 22 Oct 2013
- views: 180
close fullscreen
- Playlist
- Chat
close fullscreen
- Playlist
- Chat
7:02
Imagevideo Astellas Pharma
Astellas Pharma Imagevideo
published: 23 Oct 2015
Imagevideo Astellas Pharma
Imagevideo Astellas Pharma
- Report rights infringement
- published: 23 Oct 2015
- views: 108
2:24
Astellas Pharmaceutical Mycamine® Whistleblower Settlement
Check out the Full DOJ press release here: http://www.justice.gov/opa/pr/2014/April/14-civ...
published: 17 Apr 2014
Astellas Pharmaceutical Mycamine® Whistleblower Settlement
1:01
TV Commercial - Astellas Pharma - Myrbetriq
No Copyright Intended
Advertiser Astellas Pharma
Ad URL http://www.mybladder.com
published: 14 Mar 2014
TV Commercial - Astellas Pharma - Myrbetriq
TV Commercial - Astellas Pharma - Myrbetriq
- Report rights infringement
- published: 14 Mar 2014
- views: 11741
4:16
Astellas Pharma US, Inc. Careers.avi
Astellas corporate video
published: 09 Dec 2008
Astellas Pharma US, Inc. Careers.avi
Astellas Pharma US, Inc. Careers.avi
- Report rights infringement
- published: 09 Dec 2008
- views: 1163
6:36
Maura Bivens addresses Astellas Pharma sales meeting
My sister-in-law spoke before 1500 people at the annual sales meeting of Astellas Pharma U...
published: 18 Jun 2010
Maura Bivens addresses Astellas Pharma sales meeting
Maura Bivens addresses Astellas Pharma sales meeting
- Report rights infringement
- published: 18 Jun 2010
- views: 1111
0:31
Astellas Pharma Inc
published: 25 Oct 2011
Astellas Pharma Inc
Astellas Pharma Inc
- Report rights infringement
- published: 25 Oct 2011
- views: 1682
18:50
Tammy Sulaiman, Astellas Pharma Global Development
The adage "A picture is worth a thousand words" refers to the notion that a complex idea c...
published: 30 Apr 2014
Tammy Sulaiman, Astellas Pharma Global Development
Tammy Sulaiman, Astellas Pharma Global Development
- Report rights infringement
- published: 30 Apr 2014
- views: 282
1:21
Astellas Pharma, Tammy Sulaiman
Tammy is the Sr. Director in Strategic Operations at Astellas Pharma Global Development in...
published: 14 May 2014
Astellas Pharma, Tammy Sulaiman
Astellas Pharma, Tammy Sulaiman
- Report rights infringement
- published: 14 May 2014
- views: 258
1:17
Gevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
MEPPEL - Aan de de Hogemaat in Meppel kwam vanmorgen rond 11.00 uur het gevaarlijke gas H2...
published: 19 Sep 2012
Gevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
Gevaarlijke gas vrijgekomen bij Astellas Pharma in Meppel
- Report rights infringement
- published: 19 Sep 2012
- views: 1191
2:16
Astellas Pharma protested for HLS ties
In Illinois Astellas Pharma receives a demo for their continued support of animal cruelty ...
published: 01 Dec 2007
Astellas Pharma protested for HLS ties
Astellas Pharma protested for HLS ties
- Report rights infringement
- published: 01 Dec 2007
- views: 1887
2:31
La ricerca oncologica di Astellas Pharma
Intervista al Dott. Chris Thomson, Direttore Business Unit Oncology, Astellas Europe
published: 23 Feb 2014
La ricerca oncologica di Astellas Pharma
La ricerca oncologica di Astellas Pharma
- Report rights infringement
- published: 23 Feb 2014
- views: 161
0:39
Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
Maxygen (NASDAQ:MAXY) announced that Astellas Pharma exercised its option to purchase all ...
published: 17 Mar 2011
Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
Maxygen Announced Astellas Pharma Exercised Option To Purchase Interest In Perseid
- Report rights infringement
- published: 17 Mar 2011
- views: 196
1:06
News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
3/31/2010-The Wall Street Journal reported Wednesday that Astellas Pharma will extend a te...
published: 31 Mar 2010
News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
News Update: Astellas Pharma Extends Tender Offer for OSI Pharma Amid Weak Shareholder Response
- Report rights infringement
- published: 31 Mar 2010
- views: 530
11:32
De Vaulx Likes Secom, Astellas Pharma, Oil and Gas
Sept. 26 (Bloomberg) -- Charles De Vaulx, portfolio manager at International Value Adviser...
published: 26 Sep 2011
De Vaulx Likes Secom, Astellas Pharma, Oil and Gas
De Vaulx Likes Secom, Astellas Pharma, Oil and Gas
- Report rights infringement
- published: 26 Sep 2011
- views: 226
Imagevideo Astellas Pharma...
Astellas Pharmaceutical Mycamine® Whistleblower Se...
TV Commercial - Astellas Pharma - Myrbetriq...
Astellas Pharma US, Inc. Careers.avi...
Maura Bivens addresses Astellas Pharma sales meeti...
Astellas Pharma Inc...
Tammy Sulaiman, Astellas Pharma Global Development...
Astellas Pharma, Tammy Sulaiman...
Gevaarlijke gas vrijgekomen bij Astellas Pharma in...
Astellas Pharma protested for HLS ties...
La ricerca oncologica di Astellas Pharma...
Maxygen Announced Astellas Pharma Exercised Option...
News Update: Astellas Pharma Extends Tender Offer ...
De Vaulx Likes Secom, Astellas Pharma, Oil and Gas...
2009 workforceChicago Astellas Pharma US Panel...
Zinc Testimonials - Astellas Pharma...
Cytori in Equity Deal with Astellas Pharma...
Astellas Pharma Europ B.V. (Promotion Film for LED...
Corporate Event Video Animation | Astellas Pharma ...
Impegno in Oncologia di Astellas Pharma...
Astellas Pharma Canada, 'We're Changing Tomorrow'....
Preview: Astellas Pharma Business & Opportunity We...
Astellas Pharma: A Testing Automation Success Stor...
photo: AP / Argentina's Navy
Argentina: Navy sinks Chinese boat fishing illegally
Edit Tampa Bay Online 16 Mar 2016
BUENOS AIRES, Argentina (AP) Argentina's navy announced Tuesday that it used gunfire to sink a boat Chinese-flagged boat that was fishing illegally in national waters. China's government said it expressed its serious concern to Argentina and called for an investigation. The navy statement said the boat was intercepted Monday off the coast of Puerto Madryn, about 907 miles (1,460 kilometers) south of Buenos Aires ... ___ ... ....
photo: Sepahnews
Details From January's Iran Capture Of U.S. Sailors Keeps Getting Worse
Edit WorldNews.com 15 Mar 2016
Thousands of pages of information from devices used by U.S. sailors who were briefly detained in January were examined by Iran, an Iranian naval commander said Tuesday, Business Insider reported ... following the incident in the two months that have passed ... – WN.com, Jack Durschlag....
photo: AP / Lynne Sladky
Exit poll results: Trump, Clinton win respective primaries
Edit Tampa Bay Online 16 Mar 2016
MIAMI (AP) Donald Trump overcame a push from Florida Hispanics for favorite son Marco Rubio to capture victory in the state's Republican primary, while Hillary Clinton won with broad support on the Democratic side despite losing the youngest voters to Bernie Sanders, according to exit poll results. Sen. Rubio, a Cuban-American, drew a solid majority of the Hispanic vote including about two-thirds of Cubans ... ___ ... Meanwhile, Texas Sen ... ....
photo: AP / Charlie Neibergall
Trump wins Republican presidential primary in North Carolina
Edit Richmond Times Dispatch 16 Mar 2016
........................ ....
photo: AP / Wong Maye-E
Why North Korea might not be bluffing about its nuclear plans
Edit The Guardian 15 Mar 2016
Skeptics have dismissed the threat posed by Pyongyang’s weapons programme but the regime has a track record of getting there – eventually. Skeptics of North Korea’s nuclear threat, and there are many, have long clung to two comforting assurances. While the North has the bomb, it doesn’t have a warhead small enough to put on a long-range rocket ... Related. North Korea readying another nuclear bomb for test – Kim Jong-un ... Cause celebre ... ....
« back to news headlines
Astellas Selected as a Nadeshiko Brand Component for Excellence in Providing Opportunities for Women(pdf 107KB) (Astellas Pharma Inc)
Edit Public Technologies 16 Mar 2016
Astellas Pharma Inc) f2289bfd-44e9-4dd2-9080-40d22ade037a.pdf ... Tokyo, March 16, 2016 - Astellas Pharma Inc ... Astellas received the Diversity Management Selection 100 award in March 2014. About Astellas. Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products ... Astellas Pharma Inc ... Astellas Pharma Inc....
BRIEF-UK's CMA says not to refer Leo Pharma deal to buy Astellas Pharma portfolio to investigation
Edit Reuters 11 Mar 2016
* Decided not to refer anticipated acquisition by Leo Pharma of the portfolio of pharma dermatological products of Astellas Pharma to phase 2 investigation Source text for Eikon. Further company coverage. ....
PGA TOUR Volunteer Challenge Invites API Fans to Help Raise Funds for Charity (Arnold Palmer Invitational)
Edit Public Technologies 11 Mar 2016
(Source. Arnold Palmer Invitational). Charitable Giving Program Extends Shared PGA TOUR and Astellas Commitment to Supporting Local Communities ... From now until 2 p.m ... 'Astellas is proud to partner with the PGA TOUR as both organizations share a deep commitment to the power of volunteerism,' said Walt Johnston, senior vice president, Sales & Marketing, Urology and Hospital, Astellas Pharma US, Inc ... Original Document ... (noodl. 32571345) ....
Astellas Nominates Fellows to Leadership Council on Legal Diversity (Astellas Pharma US Inc)
Edit Public Technologies 10 Mar 2016
Astellas Pharma US Inc) ... Astellas has actively explored ways to continue cultivating diversity in all aspects of its business. The LCLD Fellows program has enabled Astellas' legal department to be on the forefront of the company's diversity efforts ... About Astellas ... You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma ... Astellas Pharma US Inc....
Results of Open-Label Trial for CRESEMBA® (isavuconazonium sulfate) Treatment of Invasive Mucormycosis Published in The Lancet Infectious Diseases (Astellas Pharma US Inc)
Edit Public Technologies 10 Mar 2016
Astellas Pharma US Inc) ... Without prompt diagnosis and treatment, mucormycosis has a mortality rate exceeding 90 percent,' said Bernie Zeiher, M.D., president of development at Astellas ... About Astellas Infectious Disease ... About Astellas ... You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma ... SOURCE Astellas Pharma US, Inc ... Astellas Pharma US Inc....
Astellas Nominates Fellows to Leadership Council on Legal Diversity
Edit PR Newswire 10 Mar 2016
Astellas has actively explored ways to continue cultivating diversity in all aspects of its business. The LCLD Fellows program has enabled Astellas' legal department to be on the forefront of the company's diversity efforts ... About Astellas ... You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma ... SOURCE Astellas ... http.//www.astellas.us....
Basilea announces that The Lancet Infectious Diseases published results from the CRESEMBA® (isavuconazole) open-label study for the treatment of mucormycosis (Basilea Pharmaceutica AG)
Edit Public Technologies 10 Mar 2016
(Source. Basilea Pharmaceutica AG). Basel, Switzerland, March 09, 2016 - Basilea Pharmaceutica Ltd. (SIX ... Prof ... CRESEMBA was co-developed with Astellas Pharma Inc. The drug was launched in the United States by Astellas in 2015 following the U.S ... Prof. Oliver A ... The drug was co-developed with Astellas Pharma Inc. under an agreement granting Astellas a license to commercialize isavuconazole in the U.S ... by Astellas in April 2015 ... About Basilea ... 2 J....
PhRMA Applauds 2016 We Work For Health Champion Award Winners (PhRMA - Pharmaceutical Research and Manufacturers of America)
Edit Public Technologies 10 Mar 2016
Joseph Latella, senior regional specialty sales manager, Astellas Pharma US Juan Nadal, M.D., vice president, medical communications, Bayer Corporation J ... fellow in worldwide PharmSci, Pfizer Diana Lenkowsky, vice president, facilities and administrative services, Purdue Pharma Alok Goel, senior manager, HR operations & special projects, Sanofi US....
MDxHealth Appoints Global Commercial Team for SelectMDx (MDxHealth SA)
Edit Public Technologies 10 Mar 2016
(Source. MDxHealth SA). IRVINE, CA, and HERSTAL, BELGIUM - March 9, 2016 - MDxHealth SA (Euronext. MDXH.BR) announced today that it has appointed a global commercial team to drive the launch of the Company's new non-invasive, urine-based test, SelectMDx(TM) for Prostate Cancer ... The team will be led by Mr ... Mr ... Before joining MDxHealth, he held various senior sales positions at Roussel Laboratoria, Lederle, Yamanouchi and Astellas Pharma ... Dr....
Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver Tissues for Drug Toxicity Testing and Liver Fibrosis Modeling (Organovo Holdings Inc)
Edit Public Technologies 10 Mar 2016
(Source. Organovo Holdings Inc). SAN DIEGO, March 10, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc ... These presentations demonstrate the broad applicability of Organovo's exVive3DTM Human Liver Model for the assessment of drug safety and the detection of multiple clinically-relevant modes of liver injury, including steatosis and fibrosis ... The presentations are as follows. ... March 15, 9.00 a.m ... Kazuhiro Tetsuka, Ph.D., Astellas Pharma Inc....
Results of Open-Label Trial for CRESEMBA® (isavuconazonium sulfate) Treatment of Invasive Mucormycosis Published in The Lancet Infectious Diseases
Edit PR Newswire 09 Mar 2016
Without prompt diagnosis and treatment, mucormycosis has a mortality rate exceeding 90 percent," said Bernie Zeiher, M.D., president of development at Astellas ... www.astellas.us/docs/cresemba.pdf. --> www.astellas.us/docs/cresemba.pdf ... About Astellas ... You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma ... SOURCE Astellas Pharma US, Inc....
Technical Data Influencing the Market - Analyst Notes on CUBA Beverage, Arch Therapeutics, Wolseley and ...
Edit Stockhouse 09 Mar 2016
CUBA Beverage Co. (OTC. CUBV), Arch Therapeutics Inc. (OTC. ARTH), Wolseley PLC (OTC. WOSYY) and Astellas Pharma Inc. (OTC. ALPMY) ... ============. Full PDF DOWNLOAD Links ... CUBV Research Package ... ============ ... - Astellas Pharma Inc.'s stock slipped by 0.79% to close Tuesday's session at USD 13.82 ... Over the last five days Astellas Pharma Inc.'s shares have declined by 4.43% and in the past one month the stock has lost 1.92% ... Astellas Pharma Inc....
Three Women You Need to Know
Edit Huffington Post 09 Mar 2016
Habiba Corodhia Mohamed. Outreach Manager, Action on Fistula. Kenya ... Generously funded by Astellas Pharma EMEA, Action on Fistula has already delivered free, life-changing fistula surgeries to 912 women to date - in large part due to the tireless work of Habiba and her team, which travels to some of the most remote corners of Kenya to educate communities about obstetric fistula and help find and refer patients for treatment. Edna Adan ... ....
- 1
- 2
- 3
- 4
- 5
- Next page »
